- Home
- OFG vs QURE Comparison
OFG vs QURE Comparison
Compare OFG & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OFG | QURE |
|---|---|---|
| Founded | 1964 | 1998 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OFG | QURE |
|---|---|---|
| Price | $42.12 | $23.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 13 |
| Target Price | $43.40 | ★ $56.25 |
| AVG Volume (30 Days) | 416.9K | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.14 | N/A |
| Revenue Next Year | $1.38 | $142.93 |
| P/E Ratio | $9.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.15 | $7.76 |
| 52 Week High | $46.11 | $71.50 |
Technical Indicators
Market Signals| Indicator | OFG | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 58.43 | 50.01 |
| Support Level | $41.27 | $20.17 |
| Resistance Level | $42.53 | $26.97 |
| Average True Range (ATR) | 1.01 | 2.25 |
| MACD | 0.23 | -0.23 |
| Stochastic Oscillator | 85.51 | 45.13 |
Price Performance
Historical ComparisonAbout OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.